Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 1.086
Filtrar
1.
Multimedia | Recursos Multimídia, MULTIMEDIA-SMS-SP | ID: multimedia-13550

RESUMO

Anderson Santos, neste episódio de Por dentro dos HDs, passa por uma conduta de desvio de septo nasal. Operado pela médica otorrinolaringologista, Carolina Monteiro, essa esclarece o procedimento de desobstrução do septo nasal, a sua baixa complexidade, e a enfermeira Maryana Silva complementa sobre o acompanhamento excepcional do paciente durante todo desencadeamento de cuidados.


Assuntos
Septo Nasal/cirurgia , Procedimentos Cirúrgicos Nasais
2.
J Vet Med Sci ; 86(8): 911-914, 2024 Aug 02.
Artigo em Inglês | MEDLINE | ID: mdl-38925931

RESUMO

This retrospective case study aimed to evaluate the efficacy of collagen matrix (DuraGen®) in preventing subcutaneous emphysema, a common complication following dorsal rhinotomy. Six client-owned dogs diagnosed with nasal masses using computed tomography were included in this study. Dorsal rhinotomy was performed, and a collagen matrix was used to seal bone defects before fixation of the nasal bone flap. Following collagen matrix application, all dogs recovered without notable complications. These findings suggest that the collagen matrix is a reliable and safe intervention for mitigating subcutaneous emphysema after dorsal rhinotomy.


Assuntos
Colágeno , Doenças do Cão , Enfisema Subcutâneo , Animais , Cães , Doenças do Cão/cirurgia , Colágeno/uso terapêutico , Estudos Retrospectivos , Masculino , Feminino , Enfisema Subcutâneo/veterinária , Enfisema Subcutâneo/etiologia , Complicações Pós-Operatórias/veterinária , Procedimentos Cirúrgicos Nasais/veterinária , Procedimentos Cirúrgicos Nasais/métodos
3.
Int Forum Allergy Rhinol ; 14(9): 1535-1538, 2024 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-38722280

RESUMO

KEY POINTS: The angled tip and small size of the crescent blade provide versatility for its use in a variety of endonasal procedures. The crescent blade enables cutting along 180° from the tip, ensuring a tangential cut through the mucosa, which is important for flap viability. The disposable nature of the blade ensures that it is always sharp, allowing for its use in mucosal and cartilaginous cuts.


Assuntos
Nariz , Humanos , Nariz/cirurgia , Cirurgia Endoscópica por Orifício Natural/instrumentação , Endoscopia/instrumentação , Procedimentos Cirúrgicos Nasais
4.
BMC Anesthesiol ; 24(1): 177, 2024 May 18.
Artigo em Inglês | MEDLINE | ID: mdl-38762729

RESUMO

BACKGROUND: Post-anesthetic emergence agitation is common after general anesthesia and may cause adverse consequences, such as injury as well as respiratory and circulatory complications. Emergence agitation after general anesthesia occurs more frequently in nasal surgery than in other surgical procedures. This study aimed to assess the occurrence of emergence agitation in patients undergoing nasal surgery who were extubated under deep anesthesia or when fully awake. METHODS: A total of 202 patients (18-60 years, American Society of Anesthesiologists classification: I-II) undergoing nasal surgery under general anesthesia were randomized 1:1 into two groups: a deep extubation group (group D) and an awake extubation group (group A). The primary outcome was the incidence of emergence agitation. The secondary outcomes included number of emergence agitations, sedation score, vital signs, and incidence of adverse events. RESULTS: The incidence of emergence agitation was lower in group D than in group A (34.7% vs. 72.8%; p < 0.001). Compared to group A, patients in group D had lower Richmond Agitation-Sedation Scale scores, higher Ramsay sedation scores, fewer agitation episodes, and lower mean arterial pressure when extubated and 30 min after surgery, whereas these indicators did not differ 90 min after surgery. There was no difference in the incidence of adverse events between the two groups. CONCLUSIONS: Extubation under deep anesthesia can significantly reduce emergence agitation after nasal surgery under general anesthesia without increasing the incidence of adverse events. TRIAL REGISTRATION: Registered in Clinicaltrials.gov (NCT04844333) on 14/04/2021.


Assuntos
Extubação , Anestesia Geral , Delírio do Despertar , Procedimentos Cirúrgicos Nasais , Humanos , Extubação/métodos , Feminino , Masculino , Adulto , Pessoa de Meia-Idade , Delírio do Despertar/prevenção & controle , Delírio do Despertar/epidemiologia , Delírio do Despertar/etiologia , Anestesia Geral/métodos , Procedimentos Cirúrgicos Nasais/métodos , Procedimentos Cirúrgicos Nasais/efeitos adversos , Adulto Jovem , Adolescente , Vigília , Período de Recuperação da Anestesia
5.
J Coll Physicians Surg Pak ; 34(5): 509-513, 2024 May.
Artigo em Inglês | MEDLINE | ID: mdl-38720207

RESUMO

OBJECTIVE: To investigate the role of single dose of dexmedetomidine (0.5 mcg/kg) in reducing the incidence and severity of postoperative emergence delirium (EmD). STUDY DESIGN: A randomised controlled trial. Place and Duration of the Study: Department of Anaesthesia, Security Forces Hospital, Riyadh, Saudi Arabia, from 1st December 2022 to 30th March 2023. METHODOLOGY: Patients, aged between 18-65 years, with ASA 1-3 scheduled to undergo nasal surgeries under general anaesthesia, were inducted in the study. Exclusion criteria were patient refusal, later request for removal from the study, inability to give consent, known allergy to dexmedetomidine, body mass index (BMI) more than 35, history of obstructive sleep apnoea, history of psychiatric illness, pregnancy, and presence of liver and renal diseases. The primary outcome measure of the study was the incidence of emergence delirium in the postoperative period. RESULTS: The frequency of EmD after nasal surgery was 52.38% in the control group compared to 14.28% in the dexmedetomidine group (p = 0.01). Pain scores were not statistically different between the two groups. The duration of post anaesthesia care unit (PACU) stay was significantly lesser in dexmedetomidine group (p <0.001). The satisfaction score on the visual analogue scale (VAS) was also found to be higher in patients who received intravenous dexmedetomidine (p <0.001). CONCLUSION: The use of single dose dexmedetomidine before extubation in nasal surgeries reduces the EmD and improves patient satisfaction. KEY WORDS: Dexmedetomidine, Emergence delirium, Nasal surgery, Opioid consumption, Pain control.


Assuntos
Extubação , Dexmedetomidina , Delírio do Despertar , Procedimentos Cirúrgicos Nasais , Humanos , Dexmedetomidina/administração & dosagem , Dexmedetomidina/uso terapêutico , Feminino , Masculino , Adulto , Delírio do Despertar/prevenção & controle , Delírio do Despertar/epidemiologia , Pessoa de Meia-Idade , Procedimentos Cirúrgicos Nasais/efeitos adversos , Adulto Jovem , Anestesia Geral , Adolescente , Idoso , Hipnóticos e Sedativos/administração & dosagem , Arábia Saudita , Período de Recuperação da Anestesia , Administração Intravenosa , Incidência
6.
BMC Anesthesiol ; 24(1): 194, 2024 May 30.
Artigo em Inglês | MEDLINE | ID: mdl-38816731

RESUMO

BACKGROUND: Nasal surgeries, addressing anatomical variations for form and function, require careful anesthesia administration, including dexmedetomidine and remifentanil. This meta-analysis evaluates their safety and efficacy variations in nasal surgeries, emphasizing patient comfort and optimal outcomes. METHODS: Four electronic databases (PubMed, Scopus, Web of Science, and CINAHL Complete) were searched for records in English. Studies that measure the effect of dexmedetomidine versus remifentanil on patients underwent nasal surgery were included. The Cochrane Collaboration's tool was used to assess the quality of the included studies. A random-effect model was preferred and statistical analysis was performed by Stata software version 17. RESULTS: Out of an initial pool of 63 articles, five studies were selected for this analysis. All of these chosen studies were Randomized Controlled Trials (RCTs). The meta-analysis involved a total of 302 participants, with 152 in the remifentanil group and 150 in the dexmedetomidine group. The analysis aimed to compare the effects of Dexmedetomidine and Remifentanil on heart rate (HR) and mean arterial pressure (MAP) during surgery. Both groups exhibited similar MAP and HR, with the exception of a slightly lower HR in the remifentanil group at the 15th minute of surgery (Standardized Mean Difference: -0.24 [-0.83, 0.34]). Furthermore, when evaluating the impact of these medications on post-surgery outcomes, including pain levels, the use of pain relief medications, patient-surgeon satisfaction, agitation scores, and recovery time, no significant differences were observed between the two medications in any of these aspects. CONCLUSION: In summary, the study compared Dexmedetomidine and Remifentanil in nasal surgeries anesthesia. No significant differences were found in heart rate, blood pressure, satisfaction, pain, agitation, or recovery time. The study had limitations, and future research should establish standardized protocols and consider various surgical factors.


Assuntos
Dexmedetomidina , Procedimentos Cirúrgicos Nasais , Remifentanil , Dexmedetomidina/administração & dosagem , Humanos , Remifentanil/administração & dosagem , Procedimentos Cirúrgicos Nasais/métodos , Frequência Cardíaca/efeitos dos fármacos , Ensaios Clínicos Controlados Aleatórios como Assunto/métodos , Hipnóticos e Sedativos/administração & dosagem
7.
Korean J Anesthesiol ; 77(4): 432-440, 2024 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-38711267

RESUMO

BACKGROUND: Remimazolam is an ultrashort-acting benzodiazepine. Few studies have evaluated the effects of remimazolam-based total intravenous anesthesia (TIVA) on emergence agitation (EA). This study aimed to compare the incidence and severity of EA between TIVA using remimazolam and desflurane. METHODS: This prospective randomized controlled study enrolled 76 patients who underwent nasal surgery under general anesthesia. Patients were randomized into two groups of 38 each: desflurane-nitrous oxide (N2O) (DN) and remimazolam-remifentanil (RR) groups. The same protocol was used for each group from induction to emergence, except for the use of different anesthetics during maintenance of anesthesia according to the assigned group: desflurane and nitrous oxide for the DN group and remimazolam and remifentanil for the RR group. The incidence of EA as the primary outcome was evaluated using three scales: Ricker Sedation-Agitation Scale, Richmond Agitation-Sedation Scale, and Aono's four-point agitation scale. Additionally, hemodynamic changes during emergence and postoperative sense of suffocation were compared. RESULTS: The incidence of EA was significantly lower in the RR group than in the DN group in all three types of EA assessment scales (all P < 0.001). During emergence, the change in heart rate differed between the two groups (P = 0.002). The sense of suffocation was lower in the RR group than in the DN group (P = 0.027). CONCLUSIONS: RR reduced the incidence and severity of EA in patients undergoing nasal surgery under general anesthesia. In addition, RR was favorable for managing hemodynamics and postoperative sense of suffocation.


Assuntos
Anestesia Geral , Anestésicos Inalatórios , Benzodiazepinas , Desflurano , Delírio do Despertar , Procedimentos Cirúrgicos Nasais , Humanos , Masculino , Feminino , Estudos Prospectivos , Desflurano/administração & dosagem , Anestesia Geral/métodos , Anestesia Geral/efeitos adversos , Adulto , Pessoa de Meia-Idade , Delírio do Despertar/prevenção & controle , Delírio do Despertar/epidemiologia , Anestésicos Inalatórios/administração & dosagem , Anestésicos Inalatórios/efeitos adversos , Procedimentos Cirúrgicos Nasais/efeitos adversos , Procedimentos Cirúrgicos Nasais/métodos , Benzodiazepinas/administração & dosagem , Remifentanil/administração & dosagem , Período de Recuperação da Anestesia , Agitação Psicomotora/prevenção & controle , Agitação Psicomotora/etiologia
8.
Eur Arch Otorhinolaryngol ; 281(9): 4845-4853, 2024 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-38652299

RESUMO

PURPOSE: Office-based rhinologic procedures (OBRP) have become widely available in North America due to technological advances and appropriate patient selection. Nevertheless, the literature exploring the safety of these procedures remains limited. The objective of this study was to further evaluate the safety, tolerability and efficacy of these procedures with a more robust sample size to allow for capture of rare events. METHODS: A retrospective chart review of all patients who underwent OBRP from May 2015 to March 2023. Information regarding patient demographics, the indication for surgery, wait time, tolerability, intra- and postoperative complications, need for revisions, and type of revision (if applicable) was recorded. RESULTS: 1208 patients underwent OBRP during the study period. No patients were excluded. These included turbinoplasties (35%), endoscopic sinus surgeries (ESS) (26%), septoplasties (15%), nasal fracture reductions (7%), and a variety of other procedures. For ESS procedures, the anterior ethmoids and the maxillary sinuses were the most common sinuses treated. 1.1% of procedures were aborted prior to completion. The post-operative complication rate was 3.2%, with 2 major complications (significant bleeding and sepsis) encountered. The mean follow-up overall was 11 months and for ESS it was 15.8 months. CONCLUSION: Office-based rhinologic procedures are well tolerated and safe for the appropriate patient and associated with shorter wait-times as well as avoidance of general anesthesia. The complication rates are similar to or lower than previously reported rates for rhinologic surgeries done in the operating room. The low rates of revision surgery also demonstrate the efficacy of these procedures.


Assuntos
Anestesia Local , Humanos , Estudos Retrospectivos , Masculino , Feminino , Pessoa de Meia-Idade , Adulto , Idoso , Anestesia Local/métodos , Complicações Pós-Operatórias/epidemiologia , Procedimentos Cirúrgicos Ambulatórios/métodos , Procedimentos Cirúrgicos Ambulatórios/efeitos adversos , Endoscopia/métodos , Endoscopia/efeitos adversos , Adulto Jovem , Adolescente , Procedimentos Cirúrgicos Nasais/métodos , Procedimentos Cirúrgicos Nasais/efeitos adversos , Idoso de 80 Anos ou mais , Reoperação/estatística & dados numéricos
9.
Rev. otorrinolaringol. cir. cabeza cuello ; 84(1): 43-49, mar. 2024. graf
Artigo em Espanhol | LILACS | ID: biblio-1565741

RESUMO

Introducción: La cirugía endoscópica nasosinusal (CEN) de cavidades paranasales es un tratamiento ampliamente utilizado para la rinosinusitis crónica, con un impacto significativo en mejorar la calidad de vida de los pacientes. Objetivo: Evaluar el impacto de la CEN en la calidad de vida en pacientes con diagnóstico de rinosinusitis crónica en una cohorte nacional y a largo plazo (1 año). Material y Método: Se realizó un estudio de cohorte prospectiva. Se incluyó 95 pacientes con diagnóstico de RSC operados en el servicio de otorrinolaringología del hospital del Salvador en el período 2017-2021. Se compararon síntomas como obstrucción nasal, rinorrea, descarga posterior, algia facial e hiposmia, además de la encuesta SNOT-22 pre y post cirugía utilizando como medidas la escala visual análoga (EVA) de sintomatología cardinal de RSC y SNOT-22. Resultados: Los resultados mostraron una mejoría significativa en todos los síntomas evaluados. La obstrucción nasal, rinorrea, descarga posterior, hiposmia y algia facial presentaron una disminución estadísticamente significativa después de la CEN. Además, la encuesta de calidad de vida SNOT-22 reveló una mejora significativa en la calidad de vida de los pacientes después de la cirugía. Conclusión: Este estudio sugiere que la CEN podría tener un impacto significativo en la mejora de los síntomas y la calidad de vida de los pacientes con rinosinusitis crónica. Los resultados de esta cohorte nacional respaldan la efectividad de la CEN como tratamiento para esta enfermedad a largo plazo (1 año) y destacan la importancia de considerar esta opción terapéutica en el manejo de la RSC.


Introduction: Functional endoscopic sinus surgery (FESS) is a widely employed treatment for chronic rhinosinusitis (CRS) and has shown significant benefits in enhancing the quality of life for affected patients. Objective: To assess the impact of FESS on the quality of life in patients diagnosed with chronic rhinosinusitis in a national and longterm cohort (1 year). Material and Method: A prospective cohort study was conducted at the otolaryngology service of Hospital del Salvador between 2017 and 2021, involving 95 patients diagnosed with CRS who underwent FESS. Symptoms such as nasal obstruction, rhinorrhea, posterior discharge, facial pain, and hyposmia were evaluated. The visual analog scale (VAS) was used to measure the cardinal symptoms of CRS, and the SNOT-22 survey was administered before and after the surgical procedure. Results: The study demonstrated a significant improvement in all evaluated symptoms following FESS. Nasal obstruction, rhinorrhea, posterior discharge, hyposmia, and facial pain exhibited a statistically significant decrease. Moreover, the SNOT-22 survey revealed a notable enhancement in the quality of life for patients after surgery. Conclusion: The highlights of this national cohort support the impact of FESS in alleviating symptoms and improving the quality of life for patients diagnosed with chronic rhinosinusitis. The findings provide strong evidence supporting the effectiveness of FESS as a treatment option for CRS and emphasize the importance of considering this surgical approach in the management of this condition.


Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Idoso , Idoso de 80 Anos ou mais , Adulto Jovem , Endoscopia/métodos , Procedimentos Cirúrgicos Nasais/métodos , Rinossinusite/cirurgia , Seios Paranasais/cirurgia , Qualidade de Vida , Chile , Doença Crônica , Estudos Prospectivos , Inquéritos e Questionários
10.
Artigo em Inglês | MEDLINE | ID: mdl-38354852

RESUMO

INTRODUCTION AND OBJECTIVES: Nasal dermoids are uncommon midline congenital lesions in the nose, usually diagnosed in the first years of life. Imaging is mandatory to evaluate local and intracranial extension and treatment consists in surgical excision. This study aims to review the experience of the department in managing pediatric nasal dermoids using a dorsal rhinotomy surgical approach. MATERIAL AND METHODS: Retrospective case series of pediatric nasal dermoids treated at a tertiary university teaching hospital over a period of seven years. RESULTS: Nine children were treated during this period. Clinical presentation was a dermoid sinus-cyst in seven cases and a cystic lesion in two. Pre-operative imaging revealed extension of the lesion to the foramen cecum in three cases. Surgery was performed via vertical dorsal rhinotomy in all patients, and associated endoscopic surgery was used in three patients. Reconstruction with autologous material was performed in three cases. No complications or recurrences were registered during the follow-up. CONCLUSIONS: In the presented series, a vertical dorsal rhinotomy incision has provided good functional and aesthetic results. The possibility of nasal dermoid intracranial extension should be accessed with imaging but remains uncommon. In its absence, this approach may be useful and can be paired with other techniques, such as nasal endoscopy, to achieve the best outcomes.


Assuntos
Cisto Dermoide , Neoplasias Nasais , Humanos , Cisto Dermoide/cirurgia , Cisto Dermoide/diagnóstico por imagem , Neoplasias Nasais/cirurgia , Estudos Retrospectivos , Feminino , Masculino , Lactente , Pré-Escolar , Criança , Procedimentos Cirúrgicos Nasais/métodos , Endoscopia/métodos , Nariz/cirurgia , Nariz/anormalidades
12.
Int Forum Allergy Rhinol ; 14(4): 841-844, 2024 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-37615646

RESUMO

KEY POINTS: Empty nose syndrome (ENS) is characterized by a patent nasal airway and a sense of nasal obstruction. ENS and psychological symptoms improved after surgery and remained stable for up to three years. Identifying residual disease is necessary for enhancing therapeutic outcomes in ENS patients.


Assuntos
Obstrução Nasal , Procedimentos Cirúrgicos Nasais , Doenças Nasais , Humanos , Seguimentos , Doenças Nasais/diagnóstico , Nariz , Obstrução Nasal/etiologia , Procedimentos Cirúrgicos Nasais/efeitos adversos , Síndrome , Conchas Nasais/cirurgia
13.
Int Forum Allergy Rhinol ; 14(3): 630-638, 2024 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-37449456

RESUMO

BACKGROUND: Limited treatment options exist for refractory Rhinitis Medicamentosa (RM). The role of surgery after failed medical management is not well defined. Mucosal contact points and restricted airflow often perpetuate decongestant use. This study assessed the long-term outcomes of nasal surgery in patients with refractory RM. METHODS: A prospective cohort study of refractory RM treated with nasal surgery was performed with ≥12 months follow-up. Refractory RM was defined as nasal decongestant use once per day continuously for ≥4 weeks despite medical therapy. Patients with concomitant sinus disease and nonrhinitis conditions were excluded. Sinonasal Outcome Test (SNOT22), Nasal Symptom Score (NSS), and nasal medication use were assessed. Patients who ceased decongestants were compared with ongoing users. RESULTS: A total of 56 patients (age 48.4 [5.0] years, 50% female) were assessed. Median follow-up was 3.4(1.6-6.2) years. Total cessation of decongestants was achieved in 91.1%, while 5.4% had intermittent use, and 3.6% reported daily use. Ongoing users had higher odds of concomitant asthma (40.0% vs. 3.9%; odds ratio [OR], 16.33 [1.7-159.75]; p = 0.036), reduced symptom improvement (ΔSNOT22, -4.6 [15.7] vs. 27.1 [17], p = 0.009 and ΔNSS, -1.0 [4.2] vs. -6.6 [5.1], p = 0.025), and greater ongoing use of nasal corticosteroid (60.0% vs. 5.9%; OR 24.0 [2.8-203.1]) and saline sprays (40% vs. 3.9%; OR 16.3 [1.7-159.8]) but showed no difference in allergy status (OR, 0.7[0.1-7.1]), previous surgery (OR, 1.0[0.1-10.2]), gastroesophageal reflux (OR 1.0[0.1-10.2], or underlying anxiety/depression (OR 6.1[0.8-45.9]) compared with those who ceased. CONCLUSION: Surgically re-establishing a nasal airway was associated with long-term decongestant cessation and symptom improvement in medically refractory RM.


Assuntos
Procedimentos Cirúrgicos Nasais , Rinite , Humanos , Feminino , Pessoa de Meia-Idade , Masculino , Descongestionantes Nasais/uso terapêutico , Estudos Prospectivos , Rinite/tratamento farmacológico , Rinite/cirurgia , Rinite/complicações , Resultado do Tratamento
14.
Eur Arch Otorhinolaryngol ; 281(3): 1105-1114, 2024 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-37864748

RESUMO

PURPOSE: Our study goal is to review the efficacy of tranexamic acid in reducing blood loss and operative time in nasal surgeries. METHODS: We included randomized clinical trials using oral or intravenous tranexamic acid, excluded non-randomized studies, topic administration, coagulopathy, and using other drugs interfering in the coagulation cascade. Online databases, National Library of Medicine (MEDLINE-PubMED), Latin American and Caribbean Literature on Health Sciences (Lilacs), Cochrane Library, Embase and Google Scholar were used to perform the search. The review was registered in PROSPERO by no CRD42022310977. Two authors, independently, selected the articles meeting the inclusion criteria. They extracted the data and used RevMan 5 software to perform the meta-analysis. RESULTS: Our search resulted in 16 RCTs that were included in the meta-analysis totalizing 1108 patients. Studies were evaluated resulting in a low risk of bias for the five domains. The use of tranexamic acid resulted in significant reduction in duration of surgery (DOS) and intraoperative blood loss (IBL) had significant reduction. The level of evidence according to GRADE System was high in all studies and variables. CONCLUSION: Tranexamic acid has an important role in reducing intraoperative blood loss and duration of surgery. Our study has some limitations due to the low number of RCTs available in the literature.


Assuntos
Antifibrinolíticos , Procedimentos Cirúrgicos Nasais , Ácido Tranexâmico , Humanos , Ácido Tranexâmico/uso terapêutico , Perda Sanguínea Cirúrgica/prevenção & controle , Antifibrinolíticos/uso terapêutico , Duração da Cirurgia , Procedimentos Cirúrgicos Nasais/efeitos adversos
15.
HNO ; 72(1): 3-15, 2024 Jan.
Artigo em Alemão | MEDLINE | ID: mdl-37845539

RESUMO

BACKGROUND AND OBJECTIVES: This paper presents an overview on nasal packing materials which are available in Germany. The current literature is analyzed whether there are robust criteria regarding use nasal packing after sinonasal surgery, whether there are fundamental and proven advantages or disadvantages of products, and what this means in clinical practice. MATERIALS AND METHODS: Selective literature analysis using the PubMed database (key words "nasal packing", "nasal tamponade", "nasal surgery", "sinonasal surgery", or "sinus surgery"), corresponding text books and resulting secondary literature. RESULTS AND CONCLUSIONS: Because of systematic methodological shortcomings, the literature does not help in the decision-making about which nasal packing should be used after which kind of sinonasal surgery. In fact, individual approaches for the many different clinical scenarios are recommended. In principle, nasal packing aims in hemostasis, should promote wound healing, and should not result in secondary morbidity. Nasal packing materials should be smooth (non-absorbable materials), inert (absorbable materials), and should not exert excessive pressure. Using non-absorbable packing entails the risk of potentially lethal aspiration and ingestion. For safety reasons inpatient control is recommended as long as this packing is in situ. With other, uncritical packing materials and in patients with special conditions, outpatient control could be justified.


Assuntos
Procedimentos Cirúrgicos Nasais , Sinusite , Humanos , Sinusite/cirurgia , Nariz , Epistaxe/prevenção & controle , Epistaxe/cirurgia , Cicatrização , Procedimentos Cirúrgicos Nasais/métodos , Endoscopia/métodos
16.
Head Neck ; 46(2): 306-320, 2024 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-37987238

RESUMO

BACKGROUND: The study was designed to identify new landmarks in the parapharyngeal segment of the internal carotid artery (ICA) for nasopharyngectomy and describe a surgical procedure of endoscopic endonasal transpterygoid nasopharyngectomy (EETPN). METHODS: Four cadaveric specimens were injected with colored silicone and subjected to CT scanning before dissection. The nasopharyngeal skull base was exposed using the endoscopic endonasal transpterygoid approach. The clinical data of four patients with nasopharyngeal malignances who underwent EETPN were reviewed. RESULTS: The lateral edge of the longus capitis muscle medially; the foramen lacerum, petrous apex spine and the stump of the levator veli palatini muscle superior laterally; and the upper parapharyngeal ICA laterally constitute the ICA-longus capitis muscle-petrous apex spine triangle which was a novel landmark for the upper parapharyngeal segment of the ICA. CONCLUSION: The ICA-longus capitis muscle-petrous apex spine triangle are important landmarks of the upper parapharyngeal segment of the ICA.


Assuntos
Procedimentos Cirúrgicos Nasais , Nariz , Humanos , Endoscopia/métodos , Base do Crânio/cirurgia , Osso Petroso/irrigação sanguínea , Osso Petroso/cirurgia , Cadáver , Artéria Carótida Interna
17.
Braz J Otorhinolaryngol ; 90(1): 101369, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38035468

RESUMO

OBJECTIVE: This study was designed to investigate the effect of butorphanol-soaked nasal packing on analgesia and sleep quality in patients undergoing bilateral endoscopic nasal surgery. METHODS: Sixty-six patients were enrolled and randomly allocated into three groups: group B1 (butorphanol 0.03mg/kg), group B2 (butorphanol 0.04mg/kg) and group N (control group). The primary outcome was postoperative pain scores evaluated by a Visual Analogue Scale (VAS) at 2h (T1), 8h (T2), 24h (T3) and 48h (T4) after surgery. Secondary outcome was postoperative sleep quality measured using Subjective Sleep Quality Value (SSQV). RESULTS: Postoperative VAS scores of butorphanol groups were significantly lower than the control group at T2, T3 and T4. VAS scores at each time point did not differ between groups B1 and B2. On the first and second nights after surgery, SSQV was higher in butorphanol groups than in the control group. There were no significant differences in SSQV1 and SSQV2 between group B1 and group B2. The incidence of respiratory depression, dizziness, agitation and rescue analgesic use did not show difference among three groups. CONCLUSIONS: Butorphanol-soaked nasal packing can reduce pain and improve sleep quality after bilateral endoscopic nasal surgery without increasing adverse effects. A concentration of 0.03mg/kg may be appropriate for clinical application. LEVEL OF EVIDENCE: Level 1B.


Assuntos
Butorfanol , Procedimentos Cirúrgicos Nasais , Humanos , Butorfanol/efeitos adversos , Endoscopia/efeitos adversos , Dor Pós-Operatória/prevenção & controle , Nariz , Método Duplo-Cego , Analgésicos Opioides/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA